verapamil has been researched along with Protein Aggregation, Pathological in 3 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
Protein Aggregation, Pathological: A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez-Areales, FJ | 1 |
| Di Pietro, O | 1 |
| Espargaró, A | 1 |
| Vallverdú-Queralt, A | 1 |
| Galdeano, C | 1 |
| Ragusa, IM | 1 |
| Viayna, E | 1 |
| Guillou, C | 1 |
| Clos, MV | 1 |
| Pérez, B | 1 |
| Sabaté, R | 1 |
| Lamuela-Raventós, RM | 1 |
| Luque, FJ | 1 |
| Muñoz-Torrero, D | 1 |
| Lan, JS | 1 |
| Xie, SS | 1 |
| Li, SY | 1 |
| Pan, LF | 1 |
| Wang, XB | 1 |
| Kong, LY | 1 |
| Im, W | 1 |
| Ban, JJ | 1 |
| Chung, JY | 1 |
| Lee, ST | 1 |
| Chu, K | 1 |
| Kim, M | 1 |
3 other studies available for verapamil and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.
Topics: Acetylcholinesterase; Aminoquinolines; Amyloid beta-Peptides; Antioxidants; Catechols; Cholinesteras | 2014 |
Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blood-Brain B | 2014 |
Multidrug resistance protein 1 reduces the aggregation of mutant huntingtin in neuronal cells derived from the Huntington's disease R6/2 model.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Cells, Cultured | 2015 |